Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.

Not yet recruiting

• Conditions: Heart Failure With Preserved Ejection Fraction; Non Alcoholic Fatty Liver
• Interventions: Other: echocardiography

• Registration Number: NCT05822622
• Lead Sponsor: Sohag University

Brief Summary

The aim of our study to determine the demography, relation between patients with heart failure with preserved ejection fraction and those with nonalcoholic fatty liver disease in Sohag university hospital.

Detailed Description

type of the study cross sectional study to study the relationship between heart failure with preserved ejection fraction and nonalcoholic fatty liver disease.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2023-03-26
• Status Verified: 2023-04
• Study First Submitted QC: 2023-04-07
• Last Update Submitted: 2023-04-07
• Study First Posted: 2023-04-21
• Last Update Posted: 2023-04-21
• Study Start: 2023-04-29
• Primary Completion: 2023-07-01
• Study Completion: 2023-08-30

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

clinical diagnosis of heart failure with preserved ejection fraction.

clinical diagnosis of nonalcoholic fatty liver disease. -

Read More

Exclusion Criteria

rheumatic heart disease ,congenital heart disease , ischemic heart disease ,heart failure with reduced ejection fraction , hepatitis B virus , hepatitis C virus .

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
NAFLD(non alcoholic fatty liver disease)	echocardiography	ultrasound and transient elastographic finding of fatty liver disease, diagnostic test :echocardiography to determine heart failure with preserved ejection fraction .
HFpEF(heart failure with preserved ejection fraction)	echocardiography	chronic heart failure with echocardiographic finding of LVEF (left ventricular ejection fraction) equal or more than 50% , diagnostic test :Abdominal ultrasound and transient elastography for detecting non alcoholic fatty liver disease .

Primary Outcome Measures

Name	Time	Method
collection of results of echocardiography (those detect HFpEF) with abdominal ultrasound and transient elastography results (those detect NAFLD) and find relationship between the results.	up to 28 weeks.	looking for relationship between echocardiographic findings (that detect heart failure with preserved ejection fraction) and finding in abdominal ultrasound and transient elastography (detection of nonalcoholic fatty liver disease) to detect the relationship between those two diseases.

Trial Locations

Locations (2)

Asmaa E khalifa; 🇪🇬 Sohag, Egypt

Asmaa elsayed khalifa; 🇪🇬 Sohag, El Monshah, Egypt